Optimal revascularization strategies in patients with total occlusions: 1-year results from the syntax trial

Patrick W. Serruys; Jacques Koolen; Ted Feldman; Michael J. Mack; Elisabeth Ståhle; David R. Holmes; A. Pieter Kappetein; Marie‐Claude Morice; Antonio Colombo; Katrin Leadley; Keith D. Dawkins; Friedrich W. Mohr

doi:10.1016/j.carrev.2009.04.037

Related publications

Article2012

TCT-43 Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Friedrich Mohr, Simon Redwood, G E Venn, Antonio Colombo, Michael J. Mack, A. Pieter Kappetein, Marie‐Claude Morice, David R. Holmes, Ted Feldman, Elisabeth Ståhle, Keith D. Dawkins, Patrick W. Serruys

Journal of the American College of Cardiology

Article2015

REASONABLE REVASCULARIZATION AFTER PERCUTANEOUS CORONARY INTERVENTION: VALIDATION OF THE SYNTAX REVASCULARIZATION INDEX FROM THE SYNTAX TRIAL

Philippe Généreux, Carlos M. Campos, Vasim Farooq, Christos V. Bourantas, Friedrich Mohr, Antonio Colombo, Marie‐Angèle Morel, Ted Feldman, David Holmes, Michael J. Mack, Marie Claude Morice, Keith D. Dawkins, A. Pieter Kappetein, Tullio Palmerini, Gregg W. Stone, Patrick W. Serruys

Journal of the American College of Cardiology

Article2017

2196Five-year outcomes of bifurcation stenting: insights from the SYNTAX trial

Marco Spaziano, Andrew K. Roy, Mariama Akodad, Yves Louvard, Thierry Lefévre, Patrick W. Serruys, Bernard Chevalier, Marie‐Claude Morice

European Heart Journal

Letter2017

Chronic Total Occlusions

Vasim Farooq, Patrick W. Serruys

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2022

TCTAP A-028 Predicted and Observed Mortality at 10-Year in Patients With Bifurcation Lesion in the SYNTAX Trial

Kai Ninomiya, Patrick W. Serruys, Shinichiro Masuda, Francesco Burzotta, Marie‐Claude Morice, Michael J. Mack, David R. Holmes, Yoshinobu Onuma

Journal of the American College of Cardiology

Optimal revascularization strategies in patients with total occlusions: 1-year results from the syntax trial

Abstract

Discussion(0)

Related publications

TCT-43 Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

REASONABLE REVASCULARIZATION AFTER PERCUTANEOUS CORONARY INTERVENTION: VALIDATION OF THE SYNTAX REVASCULARIZATION INDEX FROM THE SYNTAX TRIAL

2196Five-year outcomes of bifurcation stenting: insights from the SYNTAX trial

Chronic Total Occlusions

TCTAP A-028 Predicted and Observed Mortality at 10-Year in Patients With Bifurcation Lesion in the SYNTAX Trial